| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5645458 | Annals of Allergy, Asthma & Immunology | 2017 | 6 Pages |
Abstract
IL-16, TARC, and periostin distinguish between patients with AERD and those with ARwA. These mediators, taken together rather than individually, may comprise good specific nasal markers in patients with AERD. The effects of IL-16 and TARC on TH1, TH2, and T-regulatory cell functions in AERD cannot be disregarded.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Luis Manuel MD, PhD, Fernando MD, Gabriela PhD, Juan Raymundo PhD,